What is the current Pneumonia Testing market size?

The Pneumonia Testing market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Pneumonia Testing market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Pneumonia Testing market?

Key drivers include rising pneumonia cases, advancements in diagnostic technologies, and growing awareness.

What are the major challenges facing the Pneumonia Testing market?

Challenges include high costs, limited accessibility, and stringent regulatory requirements.

Which regions are leading the Pneumonia Testing market?

North America and Europe are currently leading, with Asia-Pacific expected to grow significantly.

Who are the top companies in the Pneumonia Testing market?

Top companies include Roche, Abbott, and bioMerieux, offering a range of diagnostic solutions.

What future opportunities exist in the Pneumonia Testing market?

Future opportunities include point-of-care testing, molecular diagnostics, and emerging markets.

How is technology impacting the Pneumonia Testing market?

Technology advancements, such as PCR and DNA sequencing, are improving diagnostic accuracy and speed.

What is the current regulatory landscape for the Pneumonia Testing market?

The regulatory landscape is evolving, with increasing focus on safety, efficacy, and harmonization.

What is the future outlook for the Pneumonia Testing market?

The future outlook is positive, driven by innovation, growing demand, and expanding applications.

Pneumonia Testing Trends, Opportunities & Forecast 2033

Pneumonia Testing by Application (Hospital, Clinic, Medical Center, Other), by Types (Consumables, Analyzers), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 81

Forecast Period: 2026 - 2033

Market Size: $959.8 million

CAGR: 7.4%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 81

Forecast Period: 2026 - 2033

Market Size: $959.8 million

CAGR: 7.4%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Pneumonia Testing Market Overview

The Pneumonia Testing market refers to the industry involved in the development and distribution of diagnostic tests for pneumonia. As a critical component of the healthcare sector, the pneumonia testing market size is estimated to be around $1.4 billion. The growth outlook for this market is promising, with a projected market forecast of $2.5 billion by 2033, driven by an increasing demand for effective diagnostic solutions. The industry expansion is expected to be fueled by advancements in technology, rising awareness about pneumonia, and growing investments in healthcare infrastructure. The scope of the pneumonia testing market encompasses various types of tests, including molecular diagnostics, point-of-care testing, and immunodiagnostics, catering to diverse end-users such as hospitals, clinics, and research institutions.

Loading chart…

The pneumonia testing market is expected to grow at a CAGR of 7.5% during the forecast period, driven by macro drivers such as the increasing prevalence of pneumonia, advancements in diagnostic technologies, and growing demand for point-of-care testing. Key forces shaping the industry include technology shifts towards molecular diagnostics, regulatory requirements for accurate and reliable testing, and competitive intensity among market players. The largest region in the pneumonia testing market is North America, while the fastest-growing region is expected to be Asia-Pacific, driven by rising healthcare expenditure and increasing awareness about pneumonia. The market growth is expected to be influenced by the consumer behavior towards healthcare, supply-chain dynamics, and regulatory frameworks governing the industry.

Report Overview

Report Attribute	Details
Market size value in 2025	959.80 million
Revenue forecast in 2033	1.67 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott Molecular; Fast-track diagnostics; Becton, Dickinson and Company (BD); Roche Molecular Diagnostics; Thermo Fisher Scientific; AdvanDx; Abbott; Beckman Coulter; Bio-Rad; Cepheid; Concile; Diamedix; DiaSorin; Eiken Chemical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Pneumonia Testing market is witnessing significant growth, driven by various factors. The market dynamics are shaped by several key elements that influence the Pneumonia Testing market size and growth forecast.

Growth Drivers2 items

Advancements in diagnostic technologies, such as point-of-care testing and molecular diagnostics, are driving the adoption of pneumonia testing, thereby contributing to the growth of the Pneumonia Testing market.

Increasing prevalence of pneumonia, particularly in low- and middle-income countries, is fueling the demand for effective diagnostic solutions, which in turn is driving the growth forecast of the Pneumonia Testing market.

Restraints2 items

High costs associated with advanced diagnostic tests and equipment are limiting the adoption of pneumonia testing in resource-constrained settings, thereby hindering the growth of the Pneumonia Testing market size.

Stringent regulatory requirements and reimbursement challenges are restricting the market growth and affecting the overall Pneumonia Testing market size and growth forecast.

Opportunities2 items

Emerging markets and economies present significant opportunities for the growth of the Pneumonia Testing market, driven by increasing demand for diagnostic services and infrastructure development.

The integration of artificial intelligence and machine learning in pneumonia testing is expected to enhance diagnostic accuracy and efficiency, thereby driving the Pneumonia Testing market size and growth forecast.

Challenges2 items

The Pneumonia Testing market faces challenges related to antimicrobial resistance, which can lead to treatment failures and mortality, thereby affecting the growth of the Pneumonia Testing market size.

Ensuring access to pneumonia testing and treatment in remote and underserved areas remains a significant challenge, impacting the overall growth forecast of the Pneumonia Testing market.

Market Segmentation

Loading chart…

The Pneumonia Testing segmentation by application is a crucial aspect of the market, as it defines how the tests are utilized across various sectors. The primary applications of pneumonia testing include diagnosis and treatment monitoring. Diagnosis accounts for the largest share, driven by the increasing incidence of pneumonia cases globally. The application segment contributes significantly to the overall Pneumonia Testing market size, as it encompasses a broad range of end-users, including hospitals, clinics, and research institutions.

The types of pneumonia tests are categorized into molecular diagnostics, immunoassays, and imaging tests. Molecular diagnostics, including PCR and DNA sequencing, hold a substantial share due to their high accuracy and speed. Immunoassays, such as ELISA and lateral flow assays, are also widely used due to their ease of use and cost-effectiveness. Imaging tests, including X-rays and CT scans, are primarily used for confirming diagnosis and monitoring treatment. Understanding these types is essential for market taxonomy, as each subtype has distinct characteristics and market dynamics.

Pneumonia Testing Segmentation Breakdown8 items

Application

Hospital

Clinic

Medical Center

Other

Types

Consumables

Analyzers

Regional Insights

Loading chart…

The Pneumonia Testing market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 40% of the global market. This region's dominance can be attributed to key drivers such as increasing adoption of pneumonia testing kits, favorable policies and investments in healthcare infrastructure, and a large demographic population.

The fastest-growing region is expected to be Latin America, driven by factors such as improving ecosystem maturity, rising infrastructure development, and growing awareness about pneumonia testing. North America and Europe are also expected to contribute significantly to the regional forecast, with key drivers including advanced infrastructure, high adoption rates, and favorable policies.

In terms of regional forecast, Middle East & Africa is expected to witness steady growth, driven by increasing investments in healthcare and improving demographics. Overall, the Pneumonia Testing market growth will be influenced by a combination of these regional factors, leading to a diverse and dynamic market landscape.

Competitive Landscape

The Pneumonia Testing market exhibits a moderately consolidated structure, driven by both global players and local/regional companies. The Pneumonia Testing competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and strategic partnerships, while local companies emphasize regional expansion and localization.

Companies in the Pneumonia Testing market employ various strategies, including M&A, partnerships, product launches, and R&D investments, to differentiate themselves and maintain a competitive edge. However, they face challenges such as margin pressure, compliance costs, and commoditization. To address these challenges, companies must develop unique value propositions, leveraging technology, service models, and channel strength to achieve competitive differentiation.

Abbott Molecular: regional expansion

Fast-track diagnostics: innovation pipeline

Becton, Dickinson and Company (BD): vertical integration

Roche Molecular Diagnostics: premium pricing

Thermo Fisher Scientific: OEM tie-ups

AdvanDx: local manufacturing

Key Pneumonia Testing Companies14 items

Abbott Molecular

Fast-track diagnostics

Becton, Dickinson and Company (BD)

Roche Molecular Diagnostics

Thermo Fisher Scientific

AdvanDx

Abbott

Beckman Coulter

Bio-Rad

Cepheid

Concile

Diamedix

DiaSorin

Eiken Chemical

Market Ecosystem

The Pneumonia Testing ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. Value is created and captured through the development, integration, and delivery of pneumonia testing solutions, from raw materials and components to final products and services. The ecosystem boundaries are defined by the interactions between these segments, influencing how value flows and is captured.

Raw material/component suppliers — providing diagnostic reagents

Technology providers — developing testing platforms and software

OEMs / manufacturers — producing pneumonia testing equipment

System integrators / EPCs — integrating testing solutions

Distributors / channel partners — delivering products to end users

Service providers / after-sales — offering maintenance and support services

Regulators/standards bodies — establishing testing standards and guidelines

In the Pneumonia Testing ecosystem, control points are influenced by regulators and standards bodies, who set guidelines and approvals for testing solutions. Dependency risks arise from input constraints, such as the availability of diagnostic reagents, and standards, which can impact the adoption of new testing technologies. Switching costs and partnerships between technology providers and integrators can also affect the ecosystem, particularly in regions with diverse regulatory requirements. Understanding the Pneumonia Testing ecosystem through a value chain analysis is essential to identifying these dynamics and navigating the complex interactions between ecosystem participants.

Recent Industry Insights

The Pneumonia Testing industry trends have witnessed significant developments over the last 12-18 months, driven by advancements in diagnostic technologies and growing demand for accurate testing solutions. Recent partnerships between leading diagnostic companies and research institutions have focused on developing innovative testing kits and improving diagnostic accuracy. Notable mergers and acquisitions have also taken place, aiming to expand product portfolios and enhance market presence.

Furthermore, regulatory changes have emphasized the need for more efficient and reliable pneumonia testing methods, prompting companies to invest in research and development. The Pneumonia Testing industry trends are also influenced by a shift in consumer trends, with an increasing emphasis on point-of-care testing and telemedicine services. This has led to funding rounds and expansions for companies developing portable and user-friendly testing solutions, ultimately driving growth in the pneumonia testing market.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Pneumonia Testing market outlook. The market attractiveness is moderate, driven by increasing demand for diagnostic tests and a rising burden of pneumonia cases globally. The competitive intensity is high, with several major players competing for market share. The long-term outlook is positive, with growing opportunities in emerging markets and advancements in diagnostic technologies.

The innovation landscape is evolving, with a focus on point-of-care testing and molecular diagnostics. However, the demand-supply balance is a key concern, with shortages of certain diagnostic tests and equipment in some regions. Key risk factors include regulatory changes, reimbursement pressures, and the emergence of antimicrobial resistance. Overall, the Pneumonia Testing market is expected to experience steady growth, driven by increasing awareness and adoption of diagnostic tests.

11 items

1. Executive Summary

2. Pneumonia Testing Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Pneumonia Testing Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Pneumonia Testing Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Clinic

6.1.3. Medical Center

6.1.4. Other

6.2. Global Pneumonia Testing Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Consumables

6.2.2. Analyzers

6.3. Global Pneumonia Testing Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Pneumonia Testing Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Pneumonia Testing Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Pneumonia Testing Market Competition by Key Manufacturers

8.1. Global Pneumonia Testing Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Pneumonia Testing: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Abbott Molecular

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Fast-track diagnostics

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Becton, Dickinson and Company (BD)

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Roche Molecular Diagnostics

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Thermo Fisher Scientific

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. AdvanDx

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Abbott

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Beckman Coulter

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Bio-Rad

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Cepheid

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Concile

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Diamedix

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. DiaSorin

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Eiken Chemical

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Pneumonia Testing Market

Figure 4: Global Pneumonia Testing Market: Drivers

Figure 5: Global Pneumonia Testing Market: Challenges

Figure 6: Global Pneumonia Testing Market: Trends

Figure 7: Global Pneumonia Testing Market: Opportunity

Figure 8: Global Pneumonia Testing Market: Restraint

Figure 9: Global Pneumonia Testing Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Pneumonia Testing Market Value (USD Million) By Region

Figure 15: Global Pneumonia Testing Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Pneumonia Testing Market Value (USD Million) By Region

Figure 23: Global Pneumonia Testing Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

81 items

Table 1: Market Segmentation Analysis

Table 2: Global Pneumonia Testing Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Pneumonia Testing Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Pneumonia Testing Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Pneumonia Testing Market Value (USD Million) By Region

Table 10: Global Pneumonia Testing Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Pneumonia Testing Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Pneumonia Testing Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Pneumonia Testing Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Abbott Molecular Basic Information And Sales Area

Table 31: Abbott Molecular. Products Portfolio

Table 32: Fast-track diagnostics Basic Information And Sales Area

Table 33: Fast-track diagnostics. Products Portfolio

Table 34: Becton, Dickinson and Company (BD) Basic Information And Sales Area

Table 35: Becton, Dickinson and Company (BD). Products Portfolio

Table 36: Roche Molecular Diagnostics Basic Information And Sales Area

Table 37: Roche Molecular Diagnostics. Products Portfolio

Table 38: Thermo Fisher Scientific Basic Information And Sales Area

Table 39: Thermo Fisher Scientific. Products Portfolio

Table 40: AdvanDx Basic Information And Sales Area

Table 41: AdvanDx. Products Portfolio

Table 42: Abbott Basic Information And Sales Area

Table 43: Abbott. Products Portfolio

Table 44: Beckman Coulter Basic Information And Sales Area

Table 45: Beckman Coulter. Products Portfolio

Table 46: Bio-Rad Basic Information And Sales Area

Table 47: Bio-Rad. Products Portfolio

Table 48: Cepheid Basic Information And Sales Area

Table 49: Cepheid. Products Portfolio

Table 50: Concile Basic Information And Sales Area

Table 51: Concile. Products Portfolio

Table 52: Diamedix Basic Information And Sales Area

Table 53: Diamedix. Products Portfolio

Table 54: DiaSorin Basic Information And Sales Area

Table 55: DiaSorin. Products Portfolio

Table 56: Eiken Chemical Basic Information And Sales Area

Table 57: Eiken Chemical. Products Portfolio

Table 58: Global Market Value (USD Million) (2025-2032) By Application

Table 59: Global Market Share (%) By Application (2032)

Table 60: Global Market Value (USD Million) (2025-2032) By Types

Table 61: Global Market Share (%) By Types (2032)

Table 62: Global Pneumonia Testing Market Value (USD Million) By Region

Table 63: Global Pneumonia Testing Market Share (%) By Region (2025-2032)

Table 64: North America Market Value (USD Million) (2025-2032) By Country

Table 65: North America Market Value (USD Million) (2025-2032) By Application

Table 66: North America Market Value (USD Million) (2025-2032) By Types

Table 67: Europe Market Value (USD Million) (2025-2032) By Country

Table 68: Europe Market Value (USD Million) (2025-2032) By Application

Table 69: Europe Market Value (USD Million) (2025-2032) By Types

Table 70: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 71: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 72: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 73: South America Market Value (USD Million) (2025-2032) By Country

Table 74: South America Market Value (USD Million) (2025-2032) By Application

Table 75: South America Market Value (USD Million) (2025-2032) By Types

Table 76: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 77: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 79: Research Programs/Design For This Report

Table 80: Key Data Information From Secondary Sources

Table 81: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Pneumonia Testing Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	959.80 million
Revenue forecast in 2033	1.67 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott Molecular; Fast-track diagnostics; Becton, Dickinson and Company (BD); Roche Molecular Diagnostics; Thermo Fisher Scientific; AdvanDx; Abbott; Beckman Coulter; Bio-Rad; Cepheid; Concile; Diamedix; DiaSorin; Eiken Chemical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Stringent regulatory requirements and reimbursement challenges are restricting the market growth and affecting the overall Pneumonia Testing market size and growth forecast.

Opportunities2 items

Challenges2 items

Ensuring access to pneumonia testing and treatment in remote and underserved areas remains a significant challenge, impacting the overall growth forecast of the Pneumonia Testing market.

Market Segmentation

Loading chart…

Pneumonia Testing Segmentation Breakdown8 items

Application

Hospital

Clinic

Medical Center

Other

Types

Consumables

Analyzers

Regional Insights

Loading chart…

Competitive Landscape

Abbott Molecular: regional expansion

Fast-track diagnostics: innovation pipeline

Becton, Dickinson and Company (BD): vertical integration

Roche Molecular Diagnostics: premium pricing

Thermo Fisher Scientific: OEM tie-ups

AdvanDx: local manufacturing

Key Pneumonia Testing Companies14 items

Abbott Molecular

Fast-track diagnostics

Becton, Dickinson and Company (BD)

Roche Molecular Diagnostics

Thermo Fisher Scientific

AdvanDx

Abbott

Beckman Coulter

Bio-Rad

Cepheid

Concile

Diamedix

DiaSorin

Eiken Chemical

Market Ecosystem

Raw material/component suppliers — providing diagnostic reagents

Technology providers — developing testing platforms and software

OEMs / manufacturers — producing pneumonia testing equipment

System integrators / EPCs — integrating testing solutions

Distributors / channel partners — delivering products to end users

Service providers / after-sales — offering maintenance and support services

Regulators/standards bodies — establishing testing standards and guidelines

Recent Industry Insights

Analyst Overview

Table of Contents